TIGIT and seminoma: evaluated the immunohistochemic expression of T Cell immunoreceptor with Ig and ITIM domains (TIGIT) in 78 seminoma samples, and reported frequent expression of this immune checkpoint receptor, albeit with high variability in the relative prevalence of TIGIT+ and PD-1+ cells (77).